WTM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WTM is not a good buy right now. Momentum is weakening (bearish MACD expansion) while price sits below the key pivot (~2056.6) and hedge funds are aggressively selling. With no proprietary buy signals and earnings coming soon (2026-02-13 pre-market), the risk/reward does not favor an impatient entry at current levels.
Price/levels: Last close 2044.93, below the pivot 2056.63, with nearby support at S1 2024.21 (then S2 2004.18) and resistance at R1 2089.06 (R2 2109.09). Trend/momentum: MACD histogram is -4.522 and negatively expanding, indicating downside momentum is strengthening. RSI(6) at 42.47 is neutral-to-soft (not oversold), so there isn’t a clear rebound signal yet. Moving averages are converging, suggesting indecision rather than an established uptrend.
Intellectia Proprietary Trading Signals
Bias: Bearish-to-neutral near support; not an attractive buy until momentum stabilizes and/or price reclaims the pivot with confirmation.
No news in the last week; potential event-driven catalyst is the upcoming earnings release on 2026-02-13 (pre-market). Pattern-based forecast indicates a modest positive 1-month bias (+3.44% probability-weighted move), but near-term is small (+0.51% next day; +0.07% next week).
Hedge Funds are Selling (selling amount increased 347268.42% over the last quarter), which is a strong sentiment/positioning headwind. Technical momentum is weakening (MACD expanding negative) while price remains below pivot resistance. Earnings risk ahead could amplify downside if results/disclosure disappoint given recent YoY declines.
Latest quarter: 2025/Q3. Revenue fell to 864.2M (-9.38% YoY). Net income dropped to 112.3M (-36.37% YoY). EPS declined to 44.17 (-36.62% YoY). Overall: clear YoY contraction in top-line and profitability in the latest reported quarter, which aligns with the current lack of bullish momentum.
No analyst rating or price target change data was provided, so there is no confirmed recent trend to summarize. Wall Street pro view (inferred from available data): Pros—defensive insurance profile and potential mean reversion if support holds; Cons—recent YoY earnings deterioration, bearish technical momentum, and heavy hedge-fund selling pressure. Politicians/congress: no recent congress trading data available.
